Research News

Antimicrobial Resistance Themed Call

Wednesday, 06 November 2013 09:31

The PHR Programme is now accepting applications in response to the NIHR Antimicrobial Resistance (AMR) Themed Call. Please check the AMR Themed Call website for further information. The deadline for this call is 1pm, 19 November 2013.

We are pleased to be able to share the PHR Programme AMR themed call webinar that took place on 2 October. This session addresses some key questions and tips about remit, and how to apply to this NIHR PHR funding opportunity. Watch the webinar

HCV clinical trial and tissue biobank

Wednesday, 16 October 2013 11:59

Professor Will Irving ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ) is chief investigator for an observational study (UKCRN 11582) of 10,000 patients with laboratory evidence of HCV infection, either past or current. Information about the study is included as 'Study of the Month' in the October NIHR Specialty Group newsletter. The aim is to develop a biobank, analyse the contribution of a range of host and viral factors to disease outcome, and determine the clinical utility of routine IL-28B genotyping in the management of HCV-infected patients in the UK. For further information please contact Professor Irving.


National Institute for Health Research announces hospital trusts to host branches of the Clinical Research Network

Wednesday, 02 October 2013 11:15

The Department of Health, through the National Institute for Health Research (NIHR), has announced the15 hospital Trusts that will host the local branches of the NIHR Clinical Research Network from April 2014. The 15 Trusts will take responsibility for performing the remit of the NIHR Clinical Research Network at local level and collectively will distribute £280 million of NIHR funding per year, to support the delivery of clinical research studies in their area.

Cross-government antimicrobial resistance strategy published

Wednesday, 02 October 2013 11:13

A five-year cross-government strategy has been published to manage the increasing problem of antimicrobial resistance (AMR).

It aims to slow the development and spread of AMR by focusing activities around three strategic aims:

  • improve the knowledge and understanding of AMR
  • conserve and steward the effectiveness of existing treatments
  • stimulate the development of new antibiotics, diagnostics and novel therapies

The strategy also provides £4million to set up a new NIHR Health Protection Research Unit which will focus on AMR and healthcare associated infections and a themed research call to encourage AMR research across a range of areas.

Page 5 of 10